{
  "resourceType": "Bundle",
  "id": "processedbundledovato-es",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"
    ]
  },
  "type": "document",
  "language": "es",
  "identifier": {
    "system": "https://www.gravitatehealth.eu/sid/doc",
    "value": "EU/1/19/1370/001"
  },
  "timestamp": "2023-04-25T11:55:27Z",
  "entry": [
    {
      "fullUrl": "Composition/compositione722f6782d3f34f86982e14386c8811dll",
      "resource": {
        "resourceType": "Composition",
        "id": "compositione722f6782d3f34f86982e14386c8811dll",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/rmswi/",
            "value": "yy"
          }
        ],
        "status": "final",
        "type": {
          "coding": [
            {
              "code": "100000155538",
              "system": "https://spor.ema.europa.eu/rmswi/"
            }
          ],
          "text": "Package Leaflet"
        },
        "subject": [
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          }
        ],
        "date": "2022-04-29T13:28:17Z",
        "author": [
          {
            "reference": "Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"
          }
        ],
        "title": "TEST PURPOSES ONLY - Dovato 50 mg/300 mg comprimidos recubiertos con película",
        "attester": [
          {
            "mode": {
              "coding": [
                {
                  "code": "official",
                  "system": "http://hl7.org/fhir/composition-attestation-mode"
                }
              ]
            },
            "time": "2022-04-29T13:28:17Z"
          }
        ],
        "language": "es",
        "section": [
          {
            "title": "B. Package Leaflet",
            "code": {
              "coding": [
                {
                  "code": "100000155538",
                  "system": "https://spor.ema.europa.eu/rmswi/"
                }
              ],
              "text": "B. PACKAGE LEAFLET"
            },
            "text": {
              "status": "additional",
              "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">unavailable</div>"
            },
            "emptyReason": {
              "coding": [
                {
                  "code": "unavailable",
                  "system": "http://terminology.hl7.org/CodeSystem/list-empty-reason"
                }
              ]
            },
            "section": [
              {
                "title": "Package leaflet: Information for the user",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "Package leaflet: Information for the user"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Prospecto: información para el paciente Dovato 50 mg/300 mg comprimidos recubiertos con película dolutegravir/lamivudina <b>Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.</b><ul><li>Conserve este prospecto, ya que puede tener que volver a leerlo.</li><li>Si tiene alguna duda, consulte a su médico o farmacéutico.</li><li>Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.</li><li>Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.</li></ul></div>"
                }
              },
              {
                "title": "What is in this leaflet",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "What is in this leaflet"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Contenido del prospecto<ol><li>Qué es Dovato y para qué se utiliza</li><li>Qué necesita saber antes de empezar a tomar Dovato</li><li>Cómo tomar Dovato</li><li>Posibles efectos adversos</li><li>Conservación de Dovato</li><li>Contenido del envase e información adicional</li></ol></div>"
                }
              },
              {
                "title": "1. What Dovato 50 mg/300 mg comprimidos recubiertos con película is and what it is used for",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "1. What Dovato 50 mg/300 mg comprimidos recubiertos con película is and what it is used for"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>1. Qué es Dovato y para qué se utiliza</b> Dovato es un medicamento que contiene dos principios activos usados para tratar la infección por el virus de la inmunodeficiencia humana (VIH): dolutegravir y lamivudina. Dolutegravir pertenece al grupo de medicamentos antirretrovirales llamados inhibidores de la integrasa (INI) y lamivudina pertenece a un grupo de medicamentos antirretrovirales denominados inhibidores de la transcriptasa inversa análogos de nucleósido (ITIAN).</div>"
                }
              },
              {
                "title": "2. What you need to know before you take Dovato 50 mg/300 mg comprimidos recubiertos con película",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "2. What you need to know before you take Dovato 50 mg/300 mg comprimidos recubiertos con película"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>2. Qué necesita saber antes de empezar a tomar Dovato</b> <b>No tome Dovato</b><ul><li>si es <b>alérgico</b> (hipersensible) a dolutegravir o lamivudina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6)</li><li>si está tomando un medicamento llamado <b>fampridina</b> (también conocido como dalfampridina; utilizado para tratar la esclerosis múltiple).</li></ul></div>"
                }
              },
              {
                "title": "3. How to take Dovato 50 mg/300 mg comprimidos recubiertos con película",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "3. How to take Dovato 50 mg/300 mg comprimidos recubiertos con película"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>3. Cómo tomar Dovato</b><p>Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.</p><ul><li>La dosis recomendada de Dovato es <b>un comprimido una vez al día.</b></li></ul><p>Trague el comprimido con un poco de líquido. Dovato se puede tomar con o sin alimentos.</p></div>"
                }
              },
              {
                "title": "4. Possible side effects",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "4. Possible side effects"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>4. Posibles efectos adversos</b></p><p>Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran, <b>por lo que es muy importante que le comente a su médico cualquier cambio en su estado de salud.</b></p></div>"
                }
              },
              {
                "title": "5. How to store Dovato 50 mg/300 mg comprimidos recubiertos con película",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "5. How to store Dovato 50 mg/300 mg comprimidos recubiertos con película"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>5. Conservación de Dovato</b><p>Mantener este medicamento fuera de la vista y del alcance de los niños</p><p>No utilice este medicamento después de la fecha de caducidad que aparece en la caja y el frasco después de CAD. La fecha de caducidad es el último día del mes que se indica.</p><p>Este medicamento no requiere ninguna condición especial de conservación.</p><p>Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.</p></div>"
                }
              },
              {
                "title": "6. Contents of the pack and other information",
                "code": {
                  "coding": [
                    {
                      "code": "100000155538",
                      "system": "https://spor.ema.europa.eu/rmswi/"
                    }
                  ],
                  "text": "6. Contents of the pack and other information"
                },
                "text": {
                  "status": "additional",
                  "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>6. Contenido del envase e información adicional</b> <b>Composición de Dovato</b><ul><li>Los principios activos son dolutegravir y lamivudina. Cada comprimido contiene dolutegravir sódico equivalente a 50 mg de dolutegravir y 300 mg de lamivudina.</li><li>Los demás componentes son celulosa microcristalina, carboximetilalmidón sódico, estearato de magnesio, manitol (E421), povidona (K29/32), fumarato estearilo de sodio, hipromelosa (E464), macrogol, dióxido de titanio (E171).</li><li>Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.</li></ul></div>"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-dolutegravirsodium",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-dolutegravirsodium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "1Q1V9V5WYQ",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "72072",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "active"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "1Q1V9V5WYQ",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "DOLUTEGRAVIR SODIUM"
                }
              ]
            }
          },
          "strength": [
            {
              "presentationQuantity": {
                "value": 50,
                "code": "mg",
                "system": "http://unitsofmeasure.org"
              },
              "basis": {
                "coding": [
                  {
                    "code": "ACTIB",
                    "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "display": "active ingredient - basis of strength"
                  }
                ]
              }
            }
          ]
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-lamivudine",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-lamivudine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "2T8Q726O95",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "72072",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "active"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "2T8Q726O95",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "lamivudine"
                }
              ]
            }
          },
          "strength": [
            {
              "presentationQuantity": {
                "value": 300,
                "code": "mg",
                "system": "http://unitsofmeasure.org"
              },
              "basis": {
                "coding": [
                  {
                    "code": "ACTIB",
                    "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "display": "active ingredient - basis of strength"
                  }
                ]
              }
            }
          ]
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-microcrystallinecellulose",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-microcrystallinecellulose",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "OP1R32D61U",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "100000072082",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Excipient"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "OP1R32D61U",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "microcrystalline cellulose"
                }
              ]
            }
          }
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-sodiumstarchglycolate",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-sodiumstarchglycolate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "H8AV0SQX4D",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "100000072082",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Excipient"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "H8AV0SQX4D",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "sodium starch glycolate"
                }
              ]
            }
          }
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-magnesiumstearate",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-magnesiumstearate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "70097M6I30",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "100000072082",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Excipient"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "70097M6I30",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "magnesium stearate"
                }
              ]
            }
          }
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "Ingredient/ingredient-for-dovato-mannitol",
      "resource": {
        "resourceType": "Ingredient",
        "id": "ingredient-for-dovato-mannitol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "identifier": {
          "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value": "3OWL53L36A",
          "use": "official"
        },
        "role": {
          "coding": [
            {
              "code": "100000072082",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Excipient"
            }
          ]
        },
        "status": "active",
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "3OWL53L36A",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "display": "mannitol"
                }
              ]
            }
          }
        },
        "for": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          },
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          },
          {
            "reference": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ]
      }
    },
    {
      "fullUrl": "SubstanceDefinition/substance-dolutegravirsodium",
      "resource": {
        "resourceType": "SubstanceDefinition",
        "id": "substance-dolutegravirsodium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
            "value": "1Q1V9V5WYQ",
            "use": "official"
          }
        ],
        "version": "1",
        "status": {
          "coding": [
            {
              "code": "active",
              "system": "http://hl7.org/fhir/publication-status"
            }
          ]
        },
        "manufacturer": [
          {
            "reference": "Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"
          }
        ],
        "molecularWeight": [
          {
            "type": {
              "text": "exact"
            },
            "amount": {
              "value": 441.36
            }
          }
        ],
        "structure": {
          "molecularFormula": "C20H18F2N305.Na"
        },
        "name": [
          {
            "name": "(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE",
            "type": {
              "coding": [
                {
                  "code": "x",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "display": "Chemical Name"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl": "SubstanceDefinition/substance-lamivudine",
      "resource": {
        "resourceType": "SubstanceDefinition",
        "id": "substance-lamivudine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
            "value": "2T8Q726O95",
            "use": "official"
          }
        ],
        "version": "1",
        "status": {
          "coding": [
            {
              "code": "active",
              "system": "http://hl7.org/fhir/publication-status"
            }
          ]
        },
        "manufacturer": [
          {
            "reference": "Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"
          }
        ],
        "molecularWeight": [
          {
            "type": {
              "text": "exact"
            },
            "amount": {
              "value": 229.26
            }
          }
        ],
        "structure": {
          "molecularFormula": "C8H11N303S"
        },
        "name": [
          {
            "name": "(-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE",
            "type": {
              "coding": [
                {
                  "code": "x",
                  "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "display": "Chemical Name"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl": "AdministrableProductDefinition/ap-49178f16170ee8a6bc2a4361c1748d5f",
      "resource": {
        "resourceType": "AdministrableProductDefinition",
        "id": "ap-49178f16170ee8a6bc2a4361c1748d5f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://www.who-umc.org/phpid",
            "value": "123456"
          }
        ],
        "status": "active",
        "formOf": [
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          }
        ],
        "administrableDoseForm": {
          "coding": [
            {
              "code": "200000002152",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "tablet"
            }
          ]
        },
        "unitOfPresentation": {
          "coding": [
            {
              "code": "200000002152",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "tablet"
            }
          ]
        },
        "producedFrom": [
          {
            "reference": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f"
          }
        ],
        "routeOfAdministration": [
          {
            "code": {
              "coding": [
                {
                  "code": "100000073619",
                  "system": "https://spor.ema.europa.eu/rmswi",
                  "display": "Oral use"
                }
              ]
            },
            "targetSpecies": [
              {
                "code": {
                  "coding": [
                    {
                      "code": "100000109093",
                      "system": "https://spor.ema.europa.eu/rmswi",
                      "display": "Human"
                    }
                  ]
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "RegulatedAuthorization/authorization49178f16170ee8a6bc2a4361c1748d5f",
      "resource": {
        "resourceType": "RegulatedAuthorization",
        "id": "authorization49178f16170ee8a6bc2a4361c1748d5f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/pmswi",
            "value": "EU/1/19/1370/001",
            "use": "official"
          }
        ],
        "subject": [
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          }
        ],
        "type": {
          "coding": [
            {
              "code": "100000072062",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Marketing Authorisation"
            }
          ]
        },
        "status": {
          "coding": [
            {
              "code": "active",
              "system": "http://hl7.org/fhir/publication-status",
              "display": "Active"
            }
          ]
        },
        "statusDate": "2019-07-01T13:28:17Z",
        "holder": {
          "reference": "Organization/mah-31ff1af739c7dcf77386a86f8dd83d29"
        },
        "regulator": {
          "reference": "Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"
        }
      }
    },
    {
      "fullUrl": "Organization/man-173fde4cb6b1018cb7ec8ab708d3961c",
      "resource": {
        "resourceType": "Organization",
        "id": "man-173fde4cb6b1018cb7ec8ab708d3961c",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
          ]
        },
        "contact": [
          {
            "address": {
              "use": "work",
              "text": "Avda. Extremadura 3, 09400 Aranda De Duero Aranda De Duero ES",
              "type": "physical",
              "line": [
                "Avda. Extremadura 3, 09400 Aranda De Duero"
              ],
              "city": "Aranda De Duero",
              "country": "ES"
            }
          }
        ],
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/omswi",
            "value": "ORG-100004538",
            "use": "official"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "code": "220000000033",
                "system": "https://spor.ema.europa.eu/rmswi",
                "display": "Manufacturer"
              }
            ]
          }
        ],
        "name": "GLAXO WELLCOME, S.A."
      }
    },
    {
      "fullUrl": "Organization/mah-31ff1af739c7dcf77386a86f8dd83d29",
      "resource": {
        "resourceType": "Organization",
        "id": "mah-31ff1af739c7dcf77386a86f8dd83d29",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
          ]
        },
        "contact": [
          {
            "address": {
              "use": "work",
              "text": "Van Asch van Wijckstraat 55H Amersfoort NL",
              "type": "physical",
              "line": [
                "Van Asch van Wijckstraat 55H"
              ],
              "city": "Amersfoort",
              "country": "NL"
            }
          }
        ],
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/omswi",
            "value": "ORG-100012958",
            "use": "official"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "code": "220000000034",
                "system": "https://spor.ema.europa.eu/rmswi",
                "display": "Marketing authorisation holder"
              }
            ]
          }
        ],
        "name": "ViiV Healthcare BV"
      }
    },
    {
      "fullUrl": "Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1",
      "resource": {
        "resourceType": "Organization",
        "id": "mra-7c9b97127f73ff3605a10eb1c2cc24d1",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
          ]
        },
        "contact": [
          {
            "address": {
              "use": "work",
              "text": "Carretera De Martorell 41 61, Poligono Industrial Nord-Est Amsterdam NL",
              "type": "physical",
              "line": [
                "Carretera De Martorell 41 61, Poligono Industrial Nord-Est"
              ],
              "city": "Amsterdam",
              "country": "NL",
              "postalCode": "1083 HS"
            }
          }
        ],
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/omswi",
            "value": "ORG-100013412",
            "use": "official"
          }
        ],
        "active": true,
        "type": [
          {
            "coding": [
              {
                "code": "220000000032",
                "system": "https://spor.ema.europa.eu/rmswi",
                "display": "Medicines Regulatory Authority"
              }
            ]
          }
        ],
        "name": "European Medicines Agency"
      }
    },
    {
      "fullUrl": "PackagedProductDefinition/ppd-23f4e5c6d9ca952c3ffb3940859a26f8",
      "resource": {
        "resourceType": "PackagedProductDefinition",
        "id": "ppd-23f4e5c6d9ca952c3ffb3940859a26f8",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/pmswi",
            "value": "EU/1/19/1370/001",
            "use": "official"
          }
        ],
        "name": "50 mg/300 mg film-coated tablets",
        "type": {
          "coding": [
            {
              "code": "100000155527",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Chemical Medicinal Prodcut"
            }
          ]
        },
        "status": {
          "coding": [
            {
              "code": "active",
              "system": "http://hl7.org/fhir/publication-status",
              "display": "Active"
            }
          ]
        },
        "statusDate": "2012-02-07T13:28:17Z",
        "containedItemQuantity": [
          {
            "value": 30,
            "code": "{tablets}",
            "system": "http://unitsofmeasure.org"
          }
        ],
        "packaging": {
          "identifier": [
            {
              "system": "https://spor.ema.europa.eu/pmswi",
              "value": "mock-id"
            }
          ],
          "quantity": 1,
          "type": {
            "coding": [
              {
                "code": "100000073498",
                "system": "https://spor.ema.europa.eu/rmswi",
                "display": "Box"
              }
            ]
          },
          "packaging": [
            {
              "identifier": [
                {
                  "system": "https://spor.ema.europa.eu/pmswi",
                  "value": "654321"
                }
              ],
              "type": {
                "coding": [
                  {
                    "code": "100000073504",
                    "system": "https://spor.ema.europa.eu/rmswi",
                    "display": "Child-resistant closure"
                  }
                ]
              },
              "quantity": 1,
              "material": [
                {
                  "coding": [
                    {
                      "code": "200000003529",
                      "system": "https://spor.ema.europa.eu/rmswi",
                      "display": "Cardboard"
                    }
                  ]
                }
              ]
            }
          ]
        },
        "packageFor": [
          {
            "reference": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
          }
        ],
        "manufacturer": [
          {
            "reference": "Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"
          }
        ]
      }
    },
    {
      "fullUrl": "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e",
      "resource": {
        "resourceType": "MedicinalProductDefinition",
        "id": "mp16598f252d07b4784b82ba43cf9e847e",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/pmswi",
            "value": "EU/1/19/1370/001"
          },
          {
            "system": "https://www.who-umc.org/phpid",
            "value": "0x073AF2E5B92AE19E8B67635AFFB3D6CA"
          }
        ],
        "type": {
          "coding": [
            {
              "code": "MedicinalProduct",
              "system": "http://hl7.org/fhir/medicinal-product-type",
              "display": "Medicinal Product"
            }
          ]
        },
        "domain": {
          "coding": [
            {
              "code": "Human",
              "system": "http://hl7.org/fhir/medicinal-product-domain",
              "display": "Human use"
            }
          ]
        },
        "status": {
          "coding": [
            {
              "code": "active",
              "system": "http://hl7.org/fhir/publication-status",
              "display": "active"
            }
          ]
        },
        "legalStatusOfSupply": {
          "coding": [
            {
              "code": "100000072084",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Medicinal product subject to medical prescription"
            }
          ]
        },
        "name": [
          {
            "productName": "Dovato 50 mg/300 mg film-coated tablets",
            "type": {
              "coding": [
                {
                  "code": "220000000001",
                  "system": "https://spor.ema.europa.eu/lists/220000000000"
                }
              ],
              "text": "Full name"
            },
            "part": [
              {
                "part": "Dovato",
                "type": {
                  "coding": [
                    {
                      "code": "220000000002",
                      "system": "https://spor.ema.europa.eu/lists/220000000000"
                    }
                  ],
                  "text": "Invented name part"
                }
              },
              {
                "part": "dolutegravir/lamivudine",
                "type": {
                  "coding": [
                    {
                      "code": "220000000003",
                      "system": "https://spor.ema.europa.eu/lists/220000000000"
                    }
                  ],
                  "text": "Scientific name part"
                }
              },
              {
                "part": "50 mg/300 mg",
                "type": {
                  "coding": [
                    {
                      "code": "220000000004",
                      "system": "https://spor.ema.europa.eu/lists/220000000000"
                    }
                  ],
                  "text": "Strength part"
                }
              },
              {
                "part": "film-coated tablets",
                "type": {
                  "coding": [
                    {
                      "code": "220000000005",
                      "system": "https://spor.ema.europa.eu/lists/220000000000"
                    }
                  ],
                  "text": "Pharmaceutical dose form part"
                }
              }
            ],
            "usage": [
              {
                "country": {
                  "coding": [
                    {
                      "code": "GBR",
                      "system": "urn:iso:std:iso:3166",
                      "display": "United Kingdom"
                    }
                  ]
                },
                "jurisdiction": {
                  "coding": [
                    {
                      "code": "GBR",
                      "system": "urn:iso:std:iso:3166",
                      "display": "United Kingdom"
                    }
                  ]
                },
                "language": {
                  "coding": [
                    {
                      "code": "en",
                      "system": "urn:ietf:bcp:47",
                      "display": "English"
                    }
                  ]
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "ManufacturedItemDefinition/mid-49178f16170ee8a6bc2a4361c1748d5f",
      "resource": {
        "resourceType": "ManufacturedItemDefinition",
        "id": "mid-49178f16170ee8a6bc2a4361c1748d5f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"
          ]
        },
        "identifier": [
          {
            "system": "https://spor.ema.europa.eu/pmswi",
            "value": "EU/1/19/1370/001",
            "use": "official"
          }
        ],
        "status": "active",
        "manufacturedDoseForm": {
          "coding": [
            {
              "code": "100000073665",
              "system": "https://spor.ema.europa.eu/rmswi/",
              "display": "Film-coated tablet"
            }
          ]
        },
        "unitOfPresentation": {
          "coding": [
            {
              "code": "200000002152",
              "system": "https://spor.ema.europa.eu/rmswi",
              "display": "Tablet"
            }
          ]
        },
        "manufacturer": [
          {
            "reference": "Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"
          }
        ]
      }
    }
  ]
}
